GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Meta] the SURPASS rule is doing its job and people should stop complaining — 52 comments in the full submission. View in context.
3.8k
c/tirzepatide·submitted 2 years ago by u/throwaway_titration

[Meta] the SURPASS rule is doing its job and people should stop complaining

Labbranch of 7 comments

the SURPASS rule is doing its job and people should stop complaining, and here is what changes in practice if it goes ahead. SURMOUNT-1 ran 72 weeks with the top arm around 21% mean body weight change. SURPASS is the diabetes programme and reports glycaemic endpoints, so quoting the two interchangeably is a category…

Read the full submission and all 52 comments →

This branch

7 comments, started 2 years ago
u/certified_referenceQC105 points·2 years ago

Same experience with the appetite effect being flatter across the week rather than front-loaded.

replysharereportpermalink
u/kian_ekstrom41 points·2 years ago

Sulphur burps for the first eight days after each step, then nothing. Predictable enough that I planned my week around it.

replysharereportpermalink
u/kaia_cabrera10 points·2 years ago

zepbound and mounjaro are the same compound with different labels

replysharereportpermalink
u/hassan_nilsen80 points·2 years ago

Weekly dosing again, half-life in the same neighbourhood as sema, so a step change takes about a month to reach steady state. Judging a new step at day five is judging noise.

replysharereportpermalink
u/santiago_villalobos37 points·2 years ago

the appetite effect is blunter than sema, in a good way, most weeks

replysharereportpermalink
u/curious_panel_only17 points·2 years ago·edited

the appetite effect is blunter than sema, in a good way, most weeks

Agreed, with one qualifier: that is the mean of the top arm and the spread around it was enormous.

replysharereportpermalink
u/throwaway_titrationOP79 points·2 years ago

the four-week step schedule is the label, not folklore

replysharereportpermalink

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.